E

NDRA

Endra Life Sciences Inc

3.45

-0.33-8.73%
After Hours: 3.530  +0.080  +2.32%19:30 04/24 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-7.40M

-9.55M

-12.77M

-11.12M

-10.75M

Net Income

-11.51M

-10.06M

-13.18M

-11.23M

-11.73M

Depreciation/Depletion & Amortization

206.17K

275.45K

234.26K

224.42K

165.25K

Deferred Taxes

--

--

--

--

--

Non-Cash Items

3.77M

1.16M

1.20M

1.15M

2.33M

Changes in Working Capital

134.08K

-923.32K

-1.03M

-1.26M

-1.52M

Cash from Investing Activities

-12.80K

-24.72K

-202.58K

-45.00K

-75.33K

Capital Expenditures

-16.00K

-33.88K

-202.58K

-45.00K

-75.33K

Other Investing Cash Flow Items, Total

3.20K

9.16K

--

--

--

Cash from Financing Activities

7.81M

7.52M

8.40M

13.40M

11.88M

Financing Cash Flow Items

0

--

--

--

--

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

7.84M

7.52M

8.40M

13.40M

11.54M

Issuance (Retirement) of Debt, Net

-28.48K

--

--

0

337.08K

Foreign Exchange Effects

--

--

--

--

--

Net Change in Cash

395.57K

-2.06M

-4.57M

2.23M

1.05M

Cash Interest Paid

31.91K

44.99K

59.11K

57.66K

1.92K

Cash Taxes Paid

0

0

0

0

0